In this study, we used DIA MS to analyze 154 serum samples (Fig. 1A) with the aim of studying longitudinal differences between Becker muscular dystrophy (BMD) patients and Duchenne muscular dystrophy (DMD) patients and investigating potential biomarkers of dystrophin expression and functional outcome in BMD. Here, DMD is linked to Duchenne muscular dystrophy.